Observational Trial Tolerability and Efficacy of Resiquimod Gel in Patients Treated for Actinic Keratosis.
NCT01806961 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 16
Last updated 2016-08-03
Summary
Determine the recurrence rate of actinic keratosis (AK) lesions in patients with complete clinical clearance at the end of the previous trial SP848-AK-1101 at 6 and 12 months of follow-up.
Conditions
- Actinic Keratosis
Sponsors & Collaborators
-
Spirig Pharma Ltd.
lead INDUSTRY
Principal Investigators
-
Lars E French, MD · University Clinic of Dermatology, Zurich
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-01-31
- Primary Completion
- 2013-06-30
- Completion
- 2013-09-30
Countries
- Germany
- Switzerland
Study Locations
More Related Trials
-
The Real Life Topical Field Treatment of Actinic Keratosis Study
NCT02362152 ·Status: COMPLETED
-
Study of A-101 for the Treatment of Seborrheic Keratosis
NCT02260180 ·Status: COMPLETED ·Phase: PHASE2
-
A Sequential Treatment Regimen of Cryotherapy and Picato® for the Treatment of Actinic Keratosis on the Face and Scalp
NCT01541553 ·Status: COMPLETED ·Phase: PHASE3
-
Double-blind, Randomized, Vehicle- and Comparator-controlled, Multi-center Trial to Evaluate the Efficacy and Safety of LAS41007 in the Treatment of Actinic Keratosis
NCT01265602 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Ingenol Mebutate Gel 0.015% Compared to Diclofenac Sodium Gel 3% in Subjects With Actinic Keratoses on the Face or Scalp
NCT02406014 ·Status: COMPLETED ·Phase: PHASE4
-
Imiquimod and Actinic Keratoses: an Observational Study
NCT01151956 ·Status: COMPLETED
-
The Efficacy and Tolerability of Oleogel-S-10 in Patients With Actinic Keratoses
NCT00786994 ·Status: COMPLETED ·Phase: PHASE2
-
Study on the Safety and Efficacy of Bimiralisib Gel in Participants Suffering From Actinic Keratosis
NCT06319794 ·Status: COMPLETED ·Phase: PHASE2
-
Microwave Treatment for Actinic Keratosis
NCT05636800 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
A Simultaneous Treatment Regimen Compared to a Sequential Treatment Regimen With Ingenol Mebutate Gel 0.015% and 0.05% of Two Areas With Actinic Keratosis on Face/Scalp and Trunk/Extremities
NCT01787383 ·Status: COMPLETED ·Phase: PHASE3
-
Patient and Clinician Reported Outcomes for Tirbanibulin Effectiveness and Safety in Actinic Keratosis
NCT05260073 ·Status: COMPLETED
-
Risk of Squamous Cell Carcinoma on Skin Areas Treated With Ingenol Mebutate Gel, 0.015% and Imiquimod Cream, 5%
NCT01926496 ·Status: COMPLETED ·Phase: PHASE4
-
Study of Safety, Tolerability and Effectiveness of A-101 in Subjects With Seborrheic Keratosis
NCT01986920 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Study to Evaluate the Efficacy, Safety, and Tolerability of Topical VDA-1102 Ointment in Subjects With Actinic Keratosis
NCT03538951 ·Status: COMPLETED ·Phase: PHASE2
-
An A Study Assessing Subject Satisfaction With A-101 Topical Solution for Seborrheic Keratoses
NCT03487588 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Assess Recurrence of Actinic Keratosis in Participants Treated With Methyl Aminolevulinate Hydrochloride Cream or Vehicle Cream Who Achieved Complete Response to Treated Lesions in Earlier Study
NCT04269395 ·Status: TERMINATED ·Phase: PHASE3
-
A Trial to Compare the Incidence of Squamous Cell Carcinoma (SCC) and Other Skin Neoplasia on Skin Areas Treated With Ingenol Disoxate Gel or Vehicle Gel for Actinic Keratosis on Face and Chest or Scalp
NCT03115476 ·Status: TERMINATED ·Phase: PHASE3
-
Evaluation of Two Different Non-invasive Techniques to Monitor the Clearance of Actinic Keratosis Lesions
NCT00294320 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy Study & Safety Evaluation of SR-T100 Gel in Actinic Keratosis Treatment
NCT01493921 ·Status: COMPLETED ·Phase: PHASE3
-
Earliest Stage Treatment of Aktinic Keratosis With Imiquimod 3.75% Cream
NCT04842422 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Evaluate the Efficacy and Safety of Tirbanibulin Ointment in Adult Participants With Actinic Keratosis
NCT06135415 ·Status: COMPLETED ·Phase: PHASE3
-
Safety, Tolerability, and Efficacy Study of LFX453 in Actinic Keratosis Patients
NCT02404389 ·Status: COMPLETED ·Phase: PHASE2
-
Histological Confirmation of Clinical Clearance of Actinic Keratoses Following Treatment With Ingenol Mebutate Gel, 0.05%
NCT01892137 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluate RLS-1496 Topical Cream for Actinic Keratosis
NCT07340697 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Oral Isotretinoin Versus Topical Tretinoin for Actinic Keratosis
NCT02278861 ·Status: COMPLETED ·Phase: PHASE2